VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
APLS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
APLSApellis Pharmaceuticals, Inc.
$41.03$5.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAPLSQuarterly Financials

Apellis Pharmaceuticals, Inc. (APLS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Apellis Pharmaceuticals, Inc. (APLS) quarterly income statement — complete revenue, gross profit & net income history

APLS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue192.01M199.91M458.58M178.49M166.8M212.53M196.83M199.69M172.32M146.38M110.4M94.97M44.85M22.66M22.06M16.32M14.38M60.29M5.65M623K
Revenue Growth %15.12%-5.94%132.98%-10.61%-3.21%45.19%78.29%110.26%284.26%545.89%400.54%481.85%211.84%-62.41%290.37%2519.9%--75.88%774.61%-
Cost of Goods Sold40.55M29.72M24.53M14.07M34.36M40.86M33.56M23.55M20.65M19.91M22.41M8.38M7.81M2.92M1.38M82K1.25M421K149K0
COGS % of Revenue21.12%14.87%5.35%7.88%20.6%19.22%17.05%11.79%11.98%13.6%20.3%8.82%17.41%12.91%6.26%0.5%8.67%0.7%2.64%-
Gross Profit151.46M170.19M434.05M164.42M132.44M171.67M163.27M176.14M151.67M126.47M87.99M86.59M37.04M19.74M20.68M16.24M13.13M59.87M5.5M623K
Gross Margin %78.88%85.13%94.65%92.12%79.4%80.78%82.95%88.21%88.02%86.4%79.7%91.18%82.59%87.09%93.74%99.5%91.33%99.3%97.36%100%
Gross Profit Growth %14.37%-0.86%165.84%-6.65%-12.68%35.75%85.56%103.41%309.51%540.72%325.58%433.19%181.99%-67.03%275.84%2506.74%3433.5%-76.03%751.55%610.66%
Operating Expenses201.28M221.34M210.86M197.71M215.76M197.84M210.55M205.58M213.76M210.98M225.07M207.03M212.12M183.79M173.61M164.86M142.13M149.27M133.5M194.91M
OpEx % of Revenue104.83%110.72%45.98%110.76%129.36%93.09%106.97%102.95%124.05%144.14%203.87%218%473%810.97%787.15%1010.07%988.33%247.58%2362.76%31285.71%
Selling, General & Admin124.32M147.1M142.68M130.69M129.34M121.48M121.98M127.63M129.06M141.7M145.65M111.37M102.09M84.37M78.41M63.2M51.19M41.09M45.76M48.97M
SG&A % of Revenue64.75%73.58%31.11%73.22%77.55%57.16%61.97%63.92%74.89%96.81%131.93%117.27%227.65%372.27%355.49%387.23%355.93%68.15%809.96%7859.87%
Research & Development76.96M74.23M68.19M67.02M86.42M76.35M88.57M77.95M84.7M69.28M79.42M95.66M110.03M99.42M95.21M101.66M90.94M108.18M87.73M145.94M
R&D % of Revenue40.08%37.13%14.87%37.54%51.81%35.93%45%39.03%49.15%47.33%71.94%100.73%245.34%438.7%431.66%622.85%632.4%179.43%1552.8%23425.84%
Other Operating Expenses000000000000-277K-246K99K149K-289K000
Operating Income26.47M-51.14M223.18M-33.29M-83.33M-26.16M-47.28M-29.44M-62.09M-84.52M-137.08M-120.44M-175.08M-164.05M-152.94M-148.62M-129M-89.4M-128M-194.29M
Operating Margin %13.78%-25.58%48.67%-18.65%-49.96%-12.31%-24.02%-14.74%-36.03%-57.74%-124.17%-126.82%-390.41%-723.88%-693.41%-910.57%-897%-148.28%-2265.4%-31185.71%
Operating Income Growth %131.76%-95.47%572.05%-13.05%-34.21%69.04%65.51%75.55%64.54%48.48%10.37%18.96%-35.73%-83.51%-19.49%23.5%-3.54%-168.7%1.2%-68.2%
EBITDA26.47M-50.81M223.52M-32.84M-82.88M-25.72M-46.82M-28.99M-61.65M-84.03M-136.68M-120.03M-174.68M-163.63M-152.58M-148.28M-128.64M-89.02M-127.72M-193.84M
EBITDA Margin %13.78%-25.42%48.74%-18.4%-49.69%-12.1%-23.79%-14.52%-35.77%-57.41%-123.8%-126.39%-389.52%-721.99%-691.79%-908.48%-894.5%-147.65%-2260.55%-31113.8%
EBITDA Growth %131.93%-97.59%577.38%-13.26%-34.45%69.39%65.74%75.84%64.71%48.65%10.42%19.05%-35.8%-83.8%-19.46%23.5%-3.58%-168.27%1.17%-67.99%
D&A (Non-Cash Add-back)0327K339K446K446K447K457K449K444K490K405K410K399K428K357K342K360K376K274K448K
EBIT0-47.79M227.6M-30.53M-80.83M-24.53M-44.32M-28.18M-59.29M-79.75M-132.69M-114.5M-169.97M-159.72M-182.92M-147.04M-129.19M-144.72M-193.29M-215.42M
Net Interest Income0-7.34M-6.9M-8.54M-8.39M-8.14M-9.64M-6.17M-3.66M-2.85M-2.32M-1.34M-2.14M-3.16M-5.09M-7.02M-8.44M-2.98M-2.14M-3.66M
Interest Income2.91M3.5M4.38M2.61M2.66M3.4M2.89M3.18M3.3M4.55M4.99M6M5.39M4.58M2.81M1.43M98K37K144K104K
Interest Expense-10.32M10.85M11.28M11.15M11.05M11.53M12.53M9.36M6.97M7.4M7.31M7.34M7.53M7.74M7.9M8.45M8.54M3.02M2.28M3.77M
Other Income/Expense-7.32M-7.5M-6.87M-8.4M-8.56M-9.9M-9.57M-8.1M-4.16M-2.63M-2.92M-1.4M-2.41M-3.41M-37.88M-6.87M-8.73M-58.34M-67.58M-24.9M
Pretax Income19.15M-58.64M216.32M-41.69M-91.88M-36.07M-56.85M-37.54M-66.25M-87.15M-140M-121.84M-177.5M-167.46M-190.82M-155.49M-137.73M-147.74M-195.57M-219.19M
Pretax Margin %9.97%-29.33%47.17%-23.35%-55.09%-16.97%-28.88%-18.8%-38.45%-59.54%-126.82%-128.3%-395.79%-738.92%-865.17%-952.65%-957.7%-245.05%-3461.43%-35183.15%
Income Tax496K313K602K466K341K286K592K114K170K1.42M233K194K282K-1.47M446K486K1.21M196K00
Effective Tax Rate %2.59%-0.53%0.28%-1.12%-0.37%-0.79%-1.04%-0.3%-0.26%-1.63%-0.17%-0.16%-0.16%0.88%-0.23%-0.31%-0.88%-0.13%0%0%
Net Income18.66M-58.95M215.72M-42.15M-92.22M-36.35M-57.45M-37.66M-66.42M-88.58M-140.24M-122.04M-177.78M-165.99M-191.27M-155.98M-138.94M-147.93M-195.57M-219.19M
Net Margin %9.72%-29.49%47.04%-23.61%-55.29%-17.11%-29.19%-18.86%-38.55%-60.51%-127.03%-128.5%-396.42%-732.43%-867.2%-955.62%-966.1%-245.37%-3461.43%-35183.15%
Net Income Growth %120.23%-62.16%475.52%-11.93%-38.84%58.96%59.04%69.14%62.64%46.64%26.68%21.76%-27.96%-12.21%2.2%28.84%24.35%-289.02%-44.12%-84.79%
Net Income (Continuing)18.66M-58.95M215.72M-42.15M-92.22M-36.35M-57.45M-37.66M-66.42M-88.58M-140.24M-122.04M-177.78M-165.99M-191.27M-155.98M-138.94M-147.93M-195.57M-219.19M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.00-0.471.71-0.33-0.74-0.29-0.46-0.30-0.54-0.73-1.17-1.02-1.56-1.50-1.75-1.46-1.42-1.73-2.28-2.72
EPS Growth %100%-62.07%471.74%-10%-37.04%60.27%60.68%70.59%65.38%51.33%33.14%30.14%-9.86%13.29%23.25%46.32%38.79%-274.75%-27.37%-73.25%
EPS (Basic)0.00-0.471.71-0.33-0.74-0.29-0.46-0.30-0.54-0.73-1.17-1.02-1.56-1.50-1.75-1.46-1.42-1.73-2.28-2.72
Diluted Shares Outstanding0126.02M126.02M126.02M125.45M123.9M123.9M123.9M122.96M121.23M120.29M119.32M113.87M110.63M109.13M106.63M98.07M85.66M85.66M80.65M
Basic Shares Outstanding0126.02M126.02M126.02M125.45M123.9M123.9M123.9M122.96M121.23M120.29M119.32M113.87M110.63M109.13M106.63M97.84M85.66M85.66M80.65M
Dividend Payout Ratio--------------------